Gleevec Combination Prevents Resistance In Leukemia Cells
October 05, 2005
While most patients with chronic myeloid leukemia (CML) show a remarkable response to Gleevec, a small number eventually develop resistance to the drug. A new preclinical study out of the Oregon Health & Science University Cancer Institute may prove ...